Triple-negative breast cancer and its association with obesity

Molecular and Clinical Oncology
Heng SunJing Zhong

Abstract

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks expression of the estrogen and progesterone receptor and does not overexpress human epidermal growth factor 2 receptor protein. TNBC is associated with special characteristics, including aggressiveness, poor prognosis and poor response to treatment, and has been attracting increasing attention worldwide. Obesity is a well-documented factor exerting a significant effect on the development of breast cancer, including TNBC. The purpose of the present review was to focus on the association between obesity and TNBC and provide a summary of novel research findings. The aim was to highlight the association between TNBC and obesity and provide an overview of novel outlooks on clinical issues, biological rationale, novel targeted therapies and prognosis, in order to draw attention to the significance of weight management, primary prevention, early diagnosis and treatment of this intractable disease.

References

Nov 7, 1990·Journal of the National Cancer Institute·R J CoatesR L Brown
Nov 1, 1990·The Journal of Clinical Investigation·V PapaR Vigneri
Aug 15, 1974·International Journal of Cancer. Journal International Du Cancer·F de Waard, E A Baanders-van Halewijn
Apr 1, 1995·Breast Cancer Research and Treatment·I den TonkelaarH J Collette
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L HolmbergO Meirik
Jan 1, 1993·Trends in Genetics : TIG·D M Black, E Solomon
Nov 10, 1998·Circulation·B StaelsJ C Fruchart
Mar 27, 1999·Biochemical and Biophysical Research Communications·Y AritaY Matsuzawa
Jun 10, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·K HottaY Matsuzawa
May 10, 2001·The Journal of Clinical Endocrinology and Metabolism·C WeyerP A Tataranni
May 15, 2002·European Journal of Pharmacology·Tsu-Shuen TsaoJoachim Fruebis
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Oct 2, 2003·Journal of the National Cancer Institute·William D FoulkesLars A Akslen
Nov 6, 2003·International Journal of Cancer. Journal International Du Cancer·Renato BasergaKrysztof Reiss
Feb 20, 2004·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Veronica Wendy SetiawanImmaculata De Vivo
May 1, 2004·The New England Journal of Medicine·Mark R Green
May 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G BerclazUNKNOWN International Breast Cancer Study Group
Jul 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Makoto IshikawaHirokazu Nagawa
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten O NielsenCharles M Perou
Oct 29, 2004·Nature Reviews. Cancer·Nicholas TurnerAlan Ashworth
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William Pao, Vincent A Miller
May 12, 2005·Journal of Agricultural and Food Chemistry·Jack N Losso, Hiba A Bawadi
Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
Aug 23, 2005·Endocrine-related Cancer·A AgrawalJ F R Robertson
Dec 15, 2005·Archives of Pharmacal Research·Jee Hyun KangYong Kyun Roh
Dec 21, 2005·The Journal of Cell Biology·Hanna Y IrieJoan S Brugge
Mar 15, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cecilia GarofaloEva Surmacz
May 2, 2006·Molecular and Cellular Endocrinology·Rive SarfsteinHaim Werner
Nov 14, 2006·The Breast : Official Journal of the European Society of Mastology·Kalliopi P Siziopikou, Melody Cobleigh
Dec 6, 2006·Cancer·Emad A RakhaIan O Ellis

❮ Previous
Next ❯

Citations

Feb 7, 2019·Frontiers in Oncology·Raheem J PaxtonKristen Allen-Watts
Aug 23, 2020·Cancers·Christopher M WrightNicole L Simone
Aug 23, 2020·International Journal of Molecular Sciences·David N BrindleyMatthew G K Benesch
Jun 28, 2019·Frontiers in Endocrinology·Jordan W Strober, Matthew J Brady

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
F Penault-Llorca, G Viale
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Cornelia LiedtkeLajos Pusztai
© 2022 Meta ULC. All rights reserved